renalhepatic

Renalhepatic is a nonstandard descriptor used to refer to diseases, processes, or interactions involving both the kidneys and the liver. It is not a formal diagnosis, but appears in discussions of how hepatic and renal dysfunction influence one another.

The kidneys and liver collaborate in metabolism, detoxification, and excretion. Liver injury or failure can trigger kidney dysfunction through hemodynamic changes, toxin accumulation, and altered drug clearance. Conversely, severe kidney disease can affect hepatic metabolism and the clearance of bilirubin and other waste products.

A central example is hepatorenal syndrome, a functional kidney failure that occurs in the setting of advanced liver disease without intrinsic kidney pathology. Other scenarios include acute kidney injury complicating cirrhosis and certain metabolic disorders with concurrent hepatic and renal involvement.

Evaluation involves hepatic tests (ALT, AST, bilirubin, ALP, albumin, INR), renal tests (creatinine, BUN, eGFR), urinalysis, and imaging to assess structure and portal hypertension. In suspected hepatorenal syndrome, clinicians rule out other primary kidney diseases and consider liver-directed therapies.

Management targets both organs: treating liver disease, supporting renal perfusion, and avoiding nephrotoxins. In hepatorenal syndrome, approaches include plasma volume expansion with albumin and vasoconstrictor therapy; liver transplantation can reverse the syndrome in eligible patients.

Prognosis depends on the severity of liver disease and renal dysfunction; combined impairments often confer higher mortality, though transplantation offers potential reversal.

In practice, the term renalhepatic is rarely used in formal medicine; more precise terms describe specific conditions such as hepatorenal syndrome or hepatorenal interplay.